Sec Form 13G Filing - MPM BIOVENTURES II QP LP @ AVEO PHARMACEUTICALS INC

Insider filing report for Changes in Beneficial Ownership

Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2 )*

AVEO PHARMACEUTICALS, INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

053588109

(CUSIP Number)

December 31, 2013

(Date of Event Which Requires Filing of This Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 053588109


1.	Name of Reporting Persons MPM BioVentures II, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 102,222
		6.	Shared Voting Power 0
		7.	Sole Dispositive Power 102,222
		8.	Shared Dispositive Power 0
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 102,222
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11.	Percent of Class Represented by Amount in Row (9) 0.2%
12.	Type of Reporting Person (See Instructions) PN

Page 2 of 20

CUSIP No. 053588109


1.	Name of Reporting Persons MPM BioVentures II-QP, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 927,554
		6.	Shared Voting Power 0
		7.	Sole Dispositive Power 927,554
		8.	Shared Dispositive Power 0
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 927,554
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11.	Percent of Class Represented by Amount in Row (9) 1.8%
12.	Type of Reporting Person (See Instructions) PN

Page 3 of 20

CUSIP No. 053588109


1.	Name of Reporting Persons MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Germany
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 326,563
		6.	Shared Voting Power 0
		7.	Sole Dispositive Power 326,563
		8.	Shared Dispositive Power 0
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 326,563
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11.	Percent of Class Represented by Amount in Row (9) 0.6%
12.	Type of Reporting Person (See Instructions) PN

Page 4 of 20

CUSIP No. 053588109


1.	Name of Reporting Persons MPM Asset Management Investors 2002 BVII LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 15,779
		6.	Shared Voting Power 0
		7.	Sole Dispositive Power 15,779
		8.	Shared Dispositive Power 0
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 15,779
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11.	Percent of Class Represented by Amount in Row (9) 0.0%
12.	Type of Reporting Person (See Instructions) OO

Page 5 of 20

CUSIP No. 053588109


1.	Name of Reporting Persons MPM Asset Management II, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 1,356,339*
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 1,356,339*
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,356,339*
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11.	Percent of Class Represented by Amount in Row (9) 2.6%
12.	Type of Reporting Person (See Instructions) PN

*	The shares are held as follows: 927,554 by MPM BioVentures II-QP, L.P. (“BV II QP”); 102,222 by MPM BioVentures II, L.P. (“BV II”); and 326,563 by MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG (“BV KG”). The Reporting Person is the direct general partner of BV II QP, BV II and BV KG.

Page 6 of 20

CUSIP No. 053588109


1.	Name of Reporting Persons MPM Asset Management II LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 1,356,339*
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 1,356,339*
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,356,339*
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11.	Percent of Class Represented by Amount in Row (9) 2.6%
12.	Type of Reporting Person (See Instructions) OO

*	The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; and 326,563 by BV KG. The Reporting Person is the indirect general partner of BV II QP, BV II and BV KG.

Page 7 of 20

CUSIP No. 053588109


1	Name of Reporting Persons Ansbert Gadicke
2	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3	SEC USE ONLY
4	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With:		5	Sole Voting Power 0
		6	Shared Voting Power 1,372,118*
		7	Sole Dispositive Power 0
		8	Shared Dispositive Power 1,372,118*
9	Aggregate Amount Beneficially Owned by Each Reporting Person 1,372,118*
10	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11	Percent of Class Represented by Amount in Row (9) 2.7%
12	Type of Reporting Person (See Instructions) IN

The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; 15,779 by MPM Asset Management Investors 2002 BVII LLC (“AM 2002”); and 326,563 by BV KG. MPM Asset Management II, L.P. (“AM LP”) and MPM Asset Management II LLC (“AM II LLC”) are the direct and indirect general partners of BV II QP, BV II and BV KG. The Reporting Person is an investment manager of AM II LLC and AM 2002.

Page 8 of 20

CUSIP No. 053588109


1.	Name of Reporting Persons Luke Evnin
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 1,372,118*
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 1,372,118*
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,372,118*
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11.	Percent of Class Represented by Amount in Row (9) 2.7%
12.	Type of Reporting Person (See Instructions) IN

< td width="4%" valign="top" align="left">*

The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; 15,779 by AM 2002; and 326,563 by BV KG. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. The Reporting Person is an investment manager of AM II LLC and AM 2002.

Page 9 of 20

CUSIP No. 053588109


1.	Name of Reporting Persons Nicholas Galakatos
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 1,372,118*
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 1,372,118*
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,372,118*
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11.	Percent of Class Represented by Amount in Row (9) 2.7%
12.	Type of Reporting Person (See Instructions) IN

*	The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; 15,779 by AM 2002; and 326,563 by BV KG. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. The Reporting Person is an investment manager of AM II LLC and AM 2002.

Page 10 of 20

CUSIP No. 053588109


1.	Name of Reporting Persons Michael Steinmetz
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 1,372,118*
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 1,372,118*
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,372,118*
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11.	Percent of Class Represented by Amount in Row (9) 2.7%
12.	Type of Reporting Person (See Instructions) IN

*	The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; 15,779 by AM 2002; and 326,563 by BV KG. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. The Reporting Person is an investment manager of AM II LLC and AM 2002.

Page 11 of 20

CUSIP No. 053588109


1.	Name of Reporting Persons Kurt Wheeler
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) x
3.	SEC USE ONLY
4.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With:		5.	Sole Voting Power 0
		6.	Shared Voting Power 1,372,118*
		7.	Sole Dispositive Power 0
		8.	Shared Dispositive Power 1,372,118*
9.	Aggregate Amount Beneficially Owned by Each Reporting Person 1,372,118*
10.	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
11.	Percent of Class Represented by Amount in Row (9) 2.7%
12.	Type of Reporting Person (See Instructions) IN

* The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; 15,779 by AM 2002; and 326,563 by BV KG. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. The Reporting Person is an investment manager of AM II LLC and AM 2002.

Page 12 of 20

Item 1.

(a)

Name of Issuer

AVEO Pharmaceuticals, Inc.

(b)

Address of Issuer’s Principal Executive Offices

650 E. Kendall Street

Cambridge, MA 02142

Item 2.

(a)

Name of Person Filing

MPM BioVentures II, LP

MPM BioVentures II-QP, L.P.

MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG

MPM Asset Management Investors 2002 BVII LLC

MPM Asset Management II, L.P.

MPM Asset Management II LLC

Ansbert Gadicke

Luke Evnin

Nicholas Galakatos

Michael Steinmetz

Kurt Wheeler

(b)

Address of Principal Business Office or, if none, Residence

c/o MPM Capital LLC

The John Hancock Tower

200 Clarendon Street, 54^th Floor

Boston, MA 02116

(c)

Citizenship

All entities were organized in Delaware except MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG, which was organized in Germany. The individuals are all United States citizens.

(d)

Title of Class of Securities

Common Stock

(e)

CUSIP Number

053588109

Item 3.

If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable

Page 13 of 20

Item 4.

Ownership

(a)

Amount Beneficially Owned:


MPM BioVentures II, L.P.	102,222
MPM BioVentures II-QP, L.P.	927,554
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG	326,563
MPM Asset Management Investors 2002 BVII LLC	15,779
MPM Asset Management II, L.P.	1,356,339	(1)
MPM Asset Management II LLC	1,356,339	(1)
Ansbert Gadicke	1,372,118	(2)
Luke B. Evnin	1,372,118	(2)
Nicholas Galakatos	1,372,118	(2)
Michael Steinmetz	1,372,118	(2)
Kurt Wheeler	1,372,118	(2)

Percent of Class:

	< /td>
MPM BioVentures II, L.P.	0.2	%
MPM BioVentures II-QP, L.P.	1.8.	%
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG	0.6	%
MPM Asset Management Investors 2002 BVII LLC	0.0	%
MPM Asset Management II, L.P.	2.6	%
MPM Asset Management II LLC	2.6	%
Ansbert Gadicke	2.7	%
Luke B. Evnin	2.7	%
Nicholas Galakatos	2.7	%
Michael Steinmetz	2.7	%
Kurt Wheeler	2.7	%

(b)

Number of shares as to which the person has:

(i)

Sole power to vote or to direct the vote


MPM BioVentures II, L.P.			102,222
MPM BioVentures II-QP, L.P.			927,554
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG			326,563
MPM Asset Management Investors 2002 BVII LLC			15,779
MPM Asset Management II, L.P.			0
MPM Asset Management II LLC			0
Ansbert Gadicke			0
Luke B. Evnin			0
Nicholas Galakatos			0
Michael Steinmetz			0
Kurt Wheeler			0

Page 14 of 20

(ii)

Shared power to vote or to direct the vote


MPM BioVentures II, L.P.	0
MPM BioVentures II-QP, L.P.	0
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG	0
MPM Asset Management Investors 2002 BVII LLC	0
MPM Asset Management II, L.P.	1,356,339	(1)
MPM Asset Management II LLC	1,356,339	(1)
Ansbert Gadicke	1,372,118	(2)
Luke B. Evnin	1,372,118	(2)
Nicholas Galakatos	1,372,118	(2)
Michael Steinmetz	1,372,118	(2)
Kurt Wheeler	1,372,118	(2)

(iii)

Sole power to dispose or to direct the disposition of


MPM BioVentures II, LP			102,222
MPM BioVentures II-QP, L.P.			927,554
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG			326,563
MPM Asset Management Investors 2002 LLC			15,779
MPM Asset Management II, L.P.			0
MPM Asset Management II LLC			0
Ansbert Gadicke			0
Luke Evnin			0
Nicholas Galakatos			0
Michael Steinmetz			0
Kurt Wheeler			0

(iv)

Shared power to dispose or to direct the disposition of


MPM BioVentures II, LP	0
MPM BioVentures II-QP, L.P.	0
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG	0
MPM Asset Management Investors 2002 BVII LLC	0
MPM Asset Management II, L.P.	1,356,339	(1)
MPM Asset Management II LLC	1,356,339	(1)
Ansbert Gadicke	1,372,118	(2)
Luke B. Evnin	1,372,118	(2)
Nicholas Galakatos	1,372,118	(2)
Michael Steinmetz	1,372,118	(2)
Kurt Wheeler	1,372,118	(2)

(1)	The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; and 326,563 by BV KG. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG.

(2)	The shares are held as follows: 927,554 by BV II QP; 102,222 by BV II; 15,779 by AM 2002; and 326,563 by BV KG. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. The Reporting Person is an investment manager of AM II LLC and AM 2002.

Page 15 of 20

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group

Not Applicable

Item 9.

Notice of Dissolution of a Group

Not Applicable

Item 10.

Certification

Not Applicable

Page 16 of 20

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 11, 2014


MPM BIOVENTURES II, L.P.		MPM BIOVENTURES II-QP, L.P.

By:	MPM Asset Management II, L.P.,	By:	MPM Asset Management II, L.P.,
	its General Partner		its General Partner

By:	MPM Asset Management II LLC,	By:	MPM Asset Management II LLC,
	its General Partner		its General Partner

By:	/s/ Luke B. Evnin	By:	/s/ Luke B. Evnin
	Name: Luke B. Evnin		Name: Luke B. Evnin
	Title: Investment Manager		Title: Investment Manager

MPM BIOVENTURES GMBH & CO. PARALLEL- BETEILIGUNGS KG		MPM ASSET MANAGEMENT INVESTORS 2002 BVII LLC

By:	MPM Asset Management II LP, in its capacity as the	By:	/s/ Luke B. Evnin
Special Limited Partner			Name: Luke B. Evnin
			Title: Investment Manager

By:	MPM Asset Management II LLC, its General Partner

By:	/s/ Luke B. Evnin
	Name: Luke B. Evnin
	Title: Investment Manager

MPM ASSET MANAGEMENT II L.P.		MPM ASSET MANAGEMENT II LLC

By:	MPM Asset Management II LLC, its General Partner

By:	/s/ Luke B. Evnin	By:	/s/ Luke B. Evnin
	Name: Luke B. Evnin		Name: Luke B. Evnin
	Title: Investment Manager		Title: Investment Manager

Page 17 of 20


/s/ Ansbert Gadicke Ansbert Gadicke				/s/ Luke B. Evnin Luke B. Evnin

/s/ Nicholas Galakatos Nicholas Galakatos				/s/ Michael Steinmetz Michael Steinmetz

/s/ Kurt Wheeler Kurt Wheeler

EXHIBITS

A:	Joint Filing Agreement

Page 18 of 20

Sec Form 13G Filing - MPM BIOVENTURES II QP LP filing for AVEO PHARMACEUTICALS INC (AVEO) - 2014-02-12